Beijing Scitop Bio-tech Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Xiaojun Liu
Chief executive officer
CN¥3.4m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 4.4% |
| Management average tenure | no data |
| Board average tenure | 1.6yrs |
Recent management updates
Recent updates
Beijing Scitop Bio-tech (SZSE:300858) Will Want To Turn Around Its Return Trends
Nov 29
Beijing Scitop Bio-tech Co., Ltd.'s (SZSE:300858) Earnings Haven't Escaped The Attention Of Investors
Sep 27Weak Statutory Earnings May Not Tell The Whole Story For Beijing Scitop Bio-tech (SZSE:300858)
Aug 27Beijing Scitop Bio-tech (SZSE:300858) Will Pay A Smaller Dividend Than Last Year
Jun 29Investor Optimism Abounds Beijing Scitop Bio-tech Co., Ltd. (SZSE:300858) But Growth Is Lacking
Apr 18Beijing Scitop Bio-tech (SZSE:300858) Is Reinvesting At Lower Rates Of Return
Mar 22CEO
Xiaojun Liu (43 yo)
no data
Tenure
CN¥3,362,900
Compensation
Mr. Xiaojun Liu serves as Director and General Manager at Beijing Scitop Bio-tech Co., Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | no data | CN¥3.36m | 4.37% CN¥ 183.6m | |
| Deputy GM & Director | no data | CN¥582.00k | 4.51% CN¥ 189.6m | |
| Chairman of the Board | no data | CN¥1.77m | 19.94% CN¥ 838.0m | |
| Chairman of the Supervisory Board | no data | no data | no data | |
| Independent Director | 3.5yrs | CN¥100.00k | no data | |
| Employee Supervisor | no data | no data | no data | |
| Employee Supervisor | no data | no data | no data | |
| Independent Director | 1.6yrs | CN¥63.50k | no data | |
| Independent Director | 1.6yrs | CN¥63.50k | no data | |
| Director | 1.1yrs | no data | 6.39% CN¥ 268.7m |
1.6yrs
Average Tenure
44.5yo
Average Age
Experienced Board: 300858's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 15:07 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Scitop Bio-tech Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wendan Wang | China International Capital Corporation Limited |
| Wende Wu | Tianfeng Securities Brokerage Co., Ltd |